The DOI matches its Crossref record.
ESRD patients in 2001: global overview of patients, treatment modalities and development trends
Abstract
The number of patients treated for end‐stage renal disease (ESRD) has demonstrated continuous growth since the establishment of dialysis as a life‐sustaining therapy and advances in organ transplantation. This growth in ESRD patients is five times the world population growth (1.3%) and continues to grow beyond all early expectations, showing no sign of reaching a steady state within the next two decades. Reasons contributing to this growth are generally considered to be the globally ageing, multi‐morbid population, higher life‐expectancy of treated ESRD patients and increasing access of a generally younger patient population to treatment in countries in which access to date has been limited. Additionally, developments to either prevent renal disease or provide a superior and financially viable replacement therapy are not expected in the foreseeable future [1]. Over the years, data from renal registries have provided valuable information on renal patients. The first registry report of the European Renal Association (EDTA) was published in 1965 [2]. With only 271 patients admitted to treatment, the establishment of this registry demonstrated admirable foresight on the part of the collaborators in addressing an issue that would later confront healthcare organizations worldwide [3–5]. The motivation of the early pioneers to implement the necessary complex processes arose from the perceived benefit in pooling of patient and clinical data from a large number of clinics for the purpose of obtaining statistics on patient demographics and analysis of experience. Today, renal registries and other official organizations in numerous countries continue to present a valuable source of extensive information on various aspects of ESRD demographics, treatment practices and, increasingly, outcomes [6–23]. This information provides a base for international comparisons and aids understanding of treatment practices and policies and their implications for the well being of patients. The conclusions that can be drawn from such considerations are able to provide knowledge of value to both the medical communities and policy makers throughout the world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder, R., Massy, Z., Argiles, A., Spasovski, G., Verbeke, F., & Lameire, N. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh813 · Cited by 613
Grassmann, A., Gioberge, S., Moeller, S., & Brown, G. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi159 · Cited by 566
Self-citationThe burden of kidney disease: Improving global outcomes
Eknoyan, G., Lameire, N., Barsoum, R., Eckardt, K.-U., Levin, A., Levin, N., Locatelli, F., Macleod, A., Vanholder, R., Walker, R., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00894.x · Cited by 519
Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications
Schieppati, A., & Remuzzi, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09801.x · Cited by 447
How can we achieve global equity in provision of renal replacement therapy?
White, S. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.041715 · Cited by 291
Metadata
- Authors
- Moeller, S.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-12-01
- Volume
- 17
- Issue
- 12
- Pages
- 2071-2076
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2169075800
- Cited by
- 185
- References
- 0
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ESRD patients in 2001: global overview of patients, treatment modalities and development trends. https://app.cochat.ai/papers/10.1093/ndt/17.12.2071
- The paper
- Moeller, S. (2002). ESRD patients in 2001: global overview of patients, treatment modalities and development trends. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/17.12.2071
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.